… and therapeutic efficacy in a hamster model of SARS-CoV-2 … be quickly elicited during natural
SARS-CoV-2 infection or by … ab1 has potential for therapy and prophylaxis of SARS-CoV-2 …

… needs for COVID-19 therapy as no SARS-CoV-2-specific drugs … and therapeutic efficacy of
MW05/LALA on SARS-CoV-2 in … -based therapies for prophylactic and therapeutic treatment …

… of antiviral therapies as we previously described 5 . Here we adopted this animal model for
evaluation of hACE2-Fc prophylactic and therapeutic efficacy against SARS-CoV-2 infection …

… recommended therapeutic agents, … therapeutic activity. The results of recent studies report
that hydroxychloroquine and convalescent plasma demonstrate no efficacy against SARS-CoV…

… be targeted by therapeutic agents for treatment of SARS-CoV-2 … treatment, while oxygen
therapy is employed for intervention in … drugs/therapeutic agents and treatment for SARS-CoV-2 …

… In conclusion, the main therapeutic advance during the pandemic has been the development
of highly potent neutralizing MAbs for the prevention and treatment of SARS-CoV-2. The …

… we assessed the in vivo therapeutic activity of another neutralizing anti-SARS-CoV-2 monoclonal
antibody … 8), demonstrate improved therapeutic efficacy compared with wild-type IgG1. …

… The rapidly progressing of coronavirus disease 2019 (COVID-19) pandemic has become
a … efficacy and safety of current option of therapies for severe acute respiratory syndrome (SARS…

… generation and characterization of a highly efficacious anti-SARS-CoV-2 IgG1 neutralizing
antibody, SC31. Significantly, we show that the therapeutic efficacy of SC31 is not solely due …

… SARS-CoV-2 remains a global threat to human health … binding domain (RBD) of the
SARS-CoV-2 spike protein. Crystal … route showed potent therapeutic efficacy in the Syrian hamster …